Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-12-21 Share Issue/Capital Cha…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
211221 - Vervreemding van eigen aandelen_NED.pdf
Share Issue/Capital Change Classification · 1% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were delivered to employees as part of long-term incentive plans following option exercises. This directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/incentives, which falls under the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal announcement (gereglementeerde informatie) detailing specific transaction dates, quantities, and prices.
2021-12-21 Dutch
211203 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details transactions where UCB disposed of its own shares OTC following stock option exercises and free deliveries under Long Term Incentive (LTI) plans. This activity directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation schemes. This aligns precisely with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities.
2021-12-03 English
211203 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and it details transactions where UCB SA sold shares back to its personnel following the exercise of stock options (LTI plans) and the free delivery of shares. This activity directly relates to the company managing its own share capital, specifically repurchasing or issuing shares for employee compensation schemes. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal regulatory announcement dated December 3, 2021, referencing Belgian Royal Decree requirements.
2021-12-03 French
211203 - Vervreemding van eigen aandelen_NED.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB shares were transferred (disposed of) to employees as part of stock option plans and long-term incentive plans (LTI). This directly relates to the company buying back or issuing its own shares, specifically the disposal/delivery of shares to employees. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is short and appears to be a regulatory disclosure of these specific transactions, not a general announcement of a report.
2021-12-03 Dutch
211126 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Disposals of own shares" and details specific transactions where UCB disposed of its own shares OTC following the exercise of stock options by personnel under Long Term Incentive Programs. This directly relates to the company buying back or selling its own shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement of these transactions, not a general regulatory filing or a report announcement.
2021-11-26 English
211126 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content explicitly details the date, quantity, and price of UCB shares alienated (sold/transferred) following the exercise of stock options by personnel. This directly corresponds to the definition of a company reporting transactions involving its own shares, specifically share repurchases or issuance/disposal related to employee compensation plans. This matches the definition for 'Transaction in Own Shares' (POS). The document is a direct report of the transaction, not an announcement of a report.
2021-11-26 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.